{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:39:23Z","timestamp":1786451963153,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01-CA086402"],"award-info":[{"award-number":["U01-CA086402"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UL1RR025767"],"award-info":[{"award-number":["UL1RR025767"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.urolonc.2011.12.023","type":"journal-article","created":{"date-parts":[[2012,2,3]],"date-time":"2012-02-03T08:31:11Z","timestamp":1328257871000},"page":"1085-1092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prostate cancer risk prediction in a urology clinic in Mexico"],"prefix":"10.1016","volume":"31","author":[{"given":"Yuanyuan","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie C.","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Louden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Jimenez-Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector R.","family":"Camarena-Reynoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2011.12.023_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2407-9-91","article-title":"Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases","volume":"9","author":"Gomez-Guerra","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2011.12.023_bib2","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.urology.2006.10.022","article-title":"External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population","volume":"68","author":"Parekh","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2011.12.023_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djj131","article-title":"Assessing prostate cancer risk: Results from the Prostate Cancer Prevention Trial","volume":"98","author":"Thompson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2011.12.023_bib4","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1200\/JCO.2007.10.6450","article-title":"Assessing individual risk for prostate cancer","volume":"25","author":"Nam","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2011.12.023_bib5","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1200\/JCO.2006.07.6836","article-title":"Prediction of prostate cancer for patients receiving finasteride: Results from the Prostate Cancer Prevention Trial","volume":"25","author":"Thompson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2011.12.023_bib6","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.juro.2008.06.038","article-title":"Predicting prostate cancer risk through incorporation of prostate cancer gene 3","volume":"180","author":"Ankerst","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.12.023_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.eururo.2009.03.029","article-title":"Prostate cancer gene 3 (PCA3): Development and internal validation of a novel biopsy nomogram","volume":"56","author":"Chun","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2011.12.023_bib8","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.juro.2009.08.056","article-title":"Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial Calculator for predicting prostate cancer detection","volume":"82","author":"Eyre","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.12.023_bib9","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.urology.2010.04.060","article-title":"Body Mass Index Adjusted Prostate-specific Antigen and Its Application for Prostate Cancer Screening","volume":"76","author":"Liang","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2011.12.023_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.eururo.2009.08.025","article-title":"A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer","volume":"57","author":"Roobol","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2011.12.023_bib11","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/pros.21286","article-title":"A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer","volume":"71","author":"Cao","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2011.12.023_bib12","first-page":"70","article-title":"American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010","volume":"60","author":"Wolf","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2011.12.023_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1464-410X.2009.08793.x","article-title":"Evaluation of the Prostate Cancer Prevention Trial Risk Calculator in a high-risk screening population","volume":"105","author":"Kaplan","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2011.12.023_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.juro.2009.10.007","article-title":"Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy","volume":"183","author":"Nguyen","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.12.023_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.juro.2010.09.101","article-title":"The Prostate Cancer Risk Calculator from the Prostate Cancer Prevention Trial underestimates the risk of high grade cancer in contemporary referral patients","volume":"185","author":"Ngo","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.12.023_bib16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.urolonc.2011.12.023_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2011.12.023_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1198\/000313008X370302","article-title":"Decision analysis for the evaluation of diagnostic tests, prediction models, and molecular markers","volume":"62","author":"Vickers","year":"2008","journal-title":"Am Stat"},{"key":"10.1016\/j.urolonc.2011.12.023_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: A framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.urolonc.2011.12.023_bib20","first-page":"208","article-title":"Cancer statistics for Hispanics, 2003","volume":"53","author":"O'Brien","year":"2003","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2011.12.023_bib21","first-page":"105","article-title":"Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening","volume":"3","author":"Gilliland","year":"1994","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2011.12.023_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1097-0045(19990401)39:1<23::AID-PROS4>3.0.CO;2-I","article-title":"Prostate cancer mortality trends in Mexico, 1980\u20131995","volume":"39","author":"Tovar-Guzman","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2011.12.023_bib23","first-page":"233","article-title":"Family history, Hispanic ethnicity, and prostate cancer risk","volume":"13","author":"Stone","year":"2003","journal-title":"Ethn Dis"},{"key":"10.1016\/j.urolonc.2011.12.023_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/pros.20713","article-title":"Prostate cancer in Mexican-Americans: Identification of risk factors","volume":"68","author":"Strom","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2011.12.023_bib25","article-title":"Population-based screening for prostate cancer: Improved outcomes in African American men","author":"Liang","year":"2011","journal-title":"Ann Urol"},{"key":"10.1016\/j.urolonc.2011.12.023_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/bimj.201100062","article-title":"Updating risk prediction tools: A case study in prostate cancer","volume":"54","author":"Ankerst","year":"2012","journal-title":"Biometrical J"},{"key":"10.1016\/j.urolonc.2011.12.023_bib27","unstructured":"Liang Y, Ankerst DP, Feng Z, et al. Likelihood of detectable prostate cancer in the general population: Implications for prostate cancer screening. Cancer Epidemiol Biomarkers Prev, unpublished (under review)."}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143911004911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143911004911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:13:32Z","timestamp":1786450412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143911004911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1078143911004911"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2011.12.023","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate cancer risk prediction in a urology clinic in Mexico","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2011.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}